{"id":"W4321850279","doi":"10.1177/20420986221146418","title":"Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Communications Research Centre Canada","funders":"Spark Therapeutics; Hemophilia Federation of America; HEMA Biologics; National Hemophilia Foundation; BioMarin Pharmaceutical; CSL Behring; Novo Nordisk; Sanofi; Pfizer; Roche; Bayer; Genentech; Britannia Pharmaceuticals; Grifols; Octapharma","keywords":"Medicine; Pharmacovigilance; Pharmacology; Intensive care medicine; Adverse effect; Family medicine; Pediatrics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006960232,0.0005303049,0.001470456,0.0001806851,0.0005800741,0.00003252095,0.0005367541,0.0002088234,0.0001408843],"category_scores_gemma":[0.00009627294,0.0003217514,0.0004443344,0.001158154,0.0003269442,0.0001943111,0.0002693149,0.002576437,0.0001176551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000548203,"about_ca_system_score_gemma":0.0002979725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003400819,"about_ca_topic_score_gemma":0.000527847,"domain_scores_codex":[0.9963304,0.001328895,0.0008215003,0.0004279761,0.0005061164,0.0005850805],"domain_scores_gemma":[0.9960632,0.0025855,0.0002897804,0.0008743707,0.00005533164,0.0001317921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001733204,0.0003697657,0.0007031142,0.002681234,0.0004962494,0.00001352243,0.001146172,0.000002583856,0.000001997817,0.00002687808,0.00007054906,0.9943146],"study_design_scores_gemma":[0.001283889,0.00006503302,0.0004422136,0.009254519,0.0006555116,0.000006613386,0.00114634,0.00002999956,0.000002137062,0.0005032351,0.9863268,0.0002837013],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006680261,0.9931005,0.0000208634,0.0006677447,0.0006777263,0.002479033,0.0003008875,0.0001967798,0.001888472],"genre_scores_gemma":[0.002635703,0.9953599,0.00005833241,0.0001606079,0.0002452858,0.0002682081,0.0007061612,0.0001025753,0.0004632388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9940309,"threshold_uncertainty_score":0.9999235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1332966043249416,"score_gpt":0.4440379314710621,"score_spread":0.3107413271461205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}